ArticleAnnals of translational medicine2022

Efficacy and safety of anti-PD-1 antibody plus regorafenib in refractory microsatellite stable metastatic colorectal cancer: a retrospective single-arm cohort study.

Rong-Rong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.